By www.reliableresearchiq.com
Global And United States Multivalent Vaccines Market Report & Forecast 2024-2031 Story
113
$ 4350
Multivalent Vaccines Report report is categorised based on following features:
1. Global Market Players
2. Geopolitical regions
3. Consumer Insights
4. Technological advancement
5. Historic and Future Analysis of the Market
GlaxoSmithKline, plc (U.K.) Pfizer, Inc (US) Merck & Co., Inc (US) Sanofi Pasteur SA (France) Astellas Pharma Inc. (Japan) CSL Limited (Australia) Emergent BioSolutions, Inc (US) Johnson & Johnson (US) MedImmune, LLC (US) Serum Institute of India Pvt. Ltd. (India) Bavarian Nordic (Denmark) Mitsubishi Tanabe Pharma Corporation (Japan) Daiichi Sankyo (Japan) Protein Sciences Corporation (US) Panacea Biotec (India)